This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Howard J Lim - Innovator in Liposomal Formulations
Introduction
Howard J Lim is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of solid tumors. His innovative work focuses on enhancing the therapeutic index of existing cancer treatments.
Latest Patents
Howard J Lim holds a patent for "Liposomal formulations of mitoxantrone." This patent describes compositions and methods that are useful for treating solid tumors in a host. The pharmaceutical compositions consist of liposomal formulations of mitoxantrone, where the liposomes are made from a mixture of cholesterol and a diacylphosphatidylcholine, preferably 1,2-sn-dimyristoyl-phosphatidylcholine. This formulation aims to improve the efficacy of mitoxantrone in cancer therapy.
Career Highlights
Howard J Lim is affiliated with the University of British Columbia, where he continues to advance research in pharmaceutical sciences. His work has the potential to significantly impact cancer treatment protocols and improve patient outcomes.
Collaborations
Some of his notable coworkers include Thomas D Madden and Marcel B Bally. Their collaborative efforts contribute to the ongoing research and development in the field of liposomal drug formulations.
Conclusion
Howard J Lim's innovative work in liposomal formulations represents a significant advancement in cancer treatment. His contributions are paving the way for more effective therapies that can enhance the quality of life for patients battling solid tumors.